The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

According to The Business Research Company’s Acute Coronary Syndrome Global Market Report 2023, the acute coronary syndrome market is expected to show promising growth in the forecast period.

The acute coronary syndrome market has exhibited robust growth, surging from $9.23 billion in 2023 to $9.86 billion in 2024. This commendable growth, representing a Compound Annual Growth Rate (CAGR) of 6.9%, is attributed to various factors in the historical period. Key drivers include public health initiatives, the widespread adoption of telemedicine and remote monitoring, improved emergency medical services, and an escalating demand for patient education.

Projected Strong Growth Ahead
Anticipating a prosperous future, the acute coronary syndrome market is expected to witness substantial growth, reaching $12.44 billion in 2028 at a CAGR of 6.0%. The forecasted surge is driven by factors such as an increasing demand for personalized medicine, the rise in interventional cardiology, growing global awareness, and the aging population.

View More On The Acute Coronary Syndrome Market Report 2023 – https://www.thebusinessresearchcompany.com/report/acute-coronary-syndrome-global-market-report

Pivotal Trends in the Forecast Period

• Advancements in Diagnostic Tools: Innovations reshaping diagnostic capabilities.
• Integration of Health Information Technology: Incorporating tech for seamless healthcare processes.
• Rapid Response Systems: Swift and efficient systems for emergency response.
• Technological Advancements: Continuous improvement in treatment technologies.

Battling the Surge in Chronic Diseases

Addressing the Rise of Chronic Diseases
The acute coronary syndrome market is poised for growth due to the escalating prevalence of chronic diseases such as coronary artery disease, ischemic heart disease, and vascular diseases. Ischemic heart disease, a chronic ailment resulting from the obstruction or narrowing of coronary arteries, is a significant driver for market growth.

Alarming Statistics
A study published in the Journal of the American College of Cardiology reveals concerning trends. Cardiovascular risk factors are expected to rise significantly among the U.S. population between 2025 and 2060. Dyslipidemia is projected to increase by 27.6%, and hypertension by 25.1%. The study highlights substantial anticipated increases in heart failure (33.4%) and ischemic heart disease (30.7%), underlining the urgency to address chronic diseases.

Key Market Players
Major players in the acute coronary syndrome market include:

• Pfizer Inc.
• Johnson and Johnson Limited
• Siemens AG
• Hoffmann-La Roche Ltd.
• Merck & Co. Inc.
• Bayer AG
• Novartis AG
• Sanofi-Aventis LLC.
• Bristol-Myers Squibb Company
• Thermo Fisher Scientific Inc.
• AstraZeneca PLC
• Abbott Laboratories
• Biotronik Inc.
• Randox Laboratories Limited
• Nihon Kohden Corporation
• Trinity Biotech plc.

Innovations in Drug Development

Elevating Treatment Through Innovation
Major companies in the acute coronary syndrome market are focusing on developing groundbreaking drugs to enhance ACS treatment. Innovative drug development is crucial in increasing the efficiency of treatment, reducing time, and optimizing resources for each patient.

A Noteworthy Example
In June 2023, AGEPHA Pharma USA LLC launched Lodoco, the first FDA-approved anti-inflammatory atheroprotective cardiovascular treatment. This drug significantly reduces the risk of heart stroke, coronary revascularization, myocardial infarction (MI), and cardiovascular death in adult patients with cardiovascular diseases, including acute coronary syndrome.

Strategic Mergers for Market Advancement

Avertix Medical’s Strategic Move
In May 2023, Avertix Medical Inc., a US-based company specializing in implantable patient alerting systems for acute coronary syndrome (ACS), merged with BIOS Acquisition Corporation for approximately $195 million. This merger aims to expand Avertix’s commercial portfolio and continue the development of innovative products, providing valuable tools for patients and healthcare providers. BIOS Acquisition Corporation is a US-based incorporated blank check company.

Insightful Market Segmentation

Understanding Market Dynamics
The acute coronary syndrome market is segmented based on:

1. Type: Non-St-Elevation Myocardial Infarction, St-Elevation Myocardial Infarction, Unstable Angina
2. Treatment: Medications, Statins, Beta blockers, ACE inhibitors, Anticoagulants, Other Treatment
3. Diagnosis: Stress Test, Blood Tests, Imaging, Other Diagnosis
4. Route Of Administration: Oral, Parenteral
5. End-User: Hospitals, Specialty clinics, Other End User

Regional Dominance
North America took the lead as the largest region in the acute coronary syndrome market in 2023, showcasing the region’s prominence in advancing healthcare solutions.

Request A Sample Of The Global Acute Coronary Syndrome Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12985&type=smp

The Acute Coronary Syndrome Global Market Report 2023  offers a comprehensive overview on the acute coronary syndrome market size, growth rate, trends and drivers, opportunities, strategies, and competitor landscape. The countries covered in the acute coronary syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The Table Of Content For The Acute Coronary Syndrome Market Include:
1. Acute Coronary Syndrome Market Executive Summary
2. Acute Coronary Syndrome Market Segments
3. Acute Coronary Syndrome Market Size And Acute Coronary Syndrome Market Growth Rate
4. Key Acute Coronary Syndrome Market Trends
5. Major Acute Coronary Syndrome Market Drivers
……
25. Key Mergers And Acquisitions In The Acute Coronary Syndrome Market
26. Top Acute Coronary Syndrome Companies
27. Acute Coronary Syndrome Market Opportunities And Strategies
28. Acute Coronary Syndrome Market, Conclusions And Recommendations
29. Appendix

View More Related Reports –
Cardiac Pacemakers Global Market Report 2023
Cardiac Arrhythmia Monitoring Devices Global Market Report 2023
Cardiac Biomarkers Testing Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model